Main Street Venture Funds Invests in Breast Cancer Recurrence Test
Posted July 22, 2010 by Matrix-Bio • No Comments
WEST LAFAYETTE, IND., July 22, 2010 – Main Street Venture Fund has just given the estimated 200,000 women diagnosed with breast cancer each year new cause for hope. The Fort Wayne-based angel investment group is investing in Matrix-Bio, Inc., a Purdue Research Park company with new technology that shows great potential for early breast cancer detection and recurrence monitoring.
No comments yet.
Sorry, the comment form is closed at this time.